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Abstract
Background The aim of this study was to determine the
cost-effectiveness of a new strategy for the preoperative
detection of patients that will likely benefit from a chole-
cystectomy, using simple criteria that can be applied by
surgeons. Criteria for a cholecystectomy indication are: (1)
having episodic pain; (2) onset of pain 1 year or less before
the outpatient clinic visit.
Methods The cost-effectiveness of the new strategy was
evaluated against current practice using a decision analytic
model. The incremental cost-effectiveness of applying
criteria for a cholecystectomy for a patient with abdominal
pain and gallstones was compared to applying no criteria.
The incremental cost-effectiveness ratio (ICER) was
expressed as extra costs to be invested to gain one more
patient with absence of pain. Scenarios were analyzed to
assess the influence of applying different criteria.
Results The new strategy of applying one out of two cri-
teria resulted in a 4 % higher mean proportion of patients
with absence of pain compared to current practice with
similar costs. The 95 % upper limit of the ICER was €4114
($4633) per extra patient with relief of upper abdominal
pain. Application of two out of two criteria resulted in a
3 % lower mean proportion of patients with absence of
pain with lower costs.
Conclusion The new strategy of using one out of two strict
selection criteria may be an effective but also a cost-ef-
fective method to reduce the proportion of patients with
pain after cholecystectomy.
Keywords Cholecystectomy  Watchful waiting 
Gallstone  Cost-effectiveness  ICER
Gallstones constitute a significant health problem in
developed societies, affecting 5–22 % of the adult popu-
lation, but only an estimated 13–22 % of gallstone carriers
will eventually become symptomatic [1, 2]. The diagnosis
of uncomplicated symptomatic gallstone disease is based
on the Rome III criteria consisting of a steady abdominal
pain, usually located in epigastrium and/or right upper
quadrant lasting 30 min or longer in the presence of radi-
ologically detected gallstones [3, 4]. However, the sensi-
tivity of these criteria is limited and 40 % of the patients
with symptomatic gallstones report far less specific
abdominal pain symptoms [5, 6].
A cholecystectomy is the therapy of first choice for
patients diagnosed with uncomplicated symptomatic
cholecystolithiasis [7]. There are no international guideli-
nes that indicate which patient to offer a cholecystectomy
or conservative treatment. Therefore, the indication to
perform a cholecystectomy lies within the surgeons’ pref-
erence leading to variations in practice and consequently
unnecessary cholecystectomies [8–11]. Annually, approx-
imately 800,000 cholecystectomies are performed in the
USA alone and the costs are estimated to be $6 billion [12].
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and Other Interventional Techniques 
Other developed countries show similar patterns of care. A
systematic review reported in this journal demonstrated
that up to 33 % of patients have persistent abdominal pain
following cholecystectomy [13].
A strategy that is effective in selecting patients with
abdominal pain and gallstones for surgery most likely to
benefit from a cholecystectomy was developed. This
strategy uses fixed selection criteria based on pain char-
acteristics that are easy to use in clinical practice. Patients
with abdominal pain and gallstones are selected for
cholecystectomy if they fulfill one of the following two
selection criteria [14, 15]: (1) episodic pain and (2) pain
onset of 1 year or less before the outpatient clinic visit.
Preoperative identification of patients with abdominal pain
and gallstones who will benefit from a cholecystectomy
from patients who will not will probably lead to more
effective use of cholecystectomies, fewer surgery-related
complications, and fewer unnecessary healthcare expenses.
We performed a model-based economic evaluation to
evaluate a strategy based on fixed criteria for selecting
patients for a cholecystectomy against current practice.
Materials and methods
The incremental cost-effectiveness of the new strategy,
restrictive care, compared with the usual care strategy was
analyzed, complying a healthcare perspective for a time
horizon of one year. A decision analytic model was used
with effectiveness expressed as absence of abdominal pain
and costs in Euros (indexed to 2014). Models were built
and analyzed using the decision analysis program TreeAge
Software, Inc Williamstown, MA, USA, 2014 version
(Fig. 1). The study was approved by the medical ethics
committee, and informed consent for this modeling study
was not needed.
Cost-effectiveness model and model input
Cholecystectomy or watchful waiting was the treatment
possibilities in both strategies. In the usual care strategy,
the indication for cholecystectomy was left to the prefer-
ence of the treating surgeon, thus without fixed selection
criteria. In the restrictive care strategy, the indication for
cholecystectomy was only made after meeting criteria as
described above.
Table 1 shows the variables used as input and the
specific data sources. A database of a prospective multi-
center cohort study was used for the probability of getting a
cholecystectomy [14]. In this database, all patients with
cholelithiasis referred for cholecystectomy that visited the
departments of surgery of one tertiary referral center and
two non-academic teaching hospitals between June 2012
and June 2014 were recorded. The same prospective
database was used for the probability of meeting the pro-
posed criteria and the relief of upper abdominal pain
afterward. The relief of pain after cholecystectomy in usual
care was based on a systematic review [13]. Following a
healthcare perspective, we only used direct medical costs
for analysis. A previous study and existing guideline prices
for the Netherlands were used to value an outpatient clinic
visit, a cholecystectomy including an overnight stay, and
surgical complications [16, 17]. Application of the criteria
itself for cholecystectomy in the restrictive care strategy
did not lead to additional costs in itself.
For every modeling, study assumptions need to be made,
which were the following in this study: Watchful waiting
included an extra outpatient clinic visit made within 1 year
in accordance with our clinical practice to reevaluate the
patient’ symptoms. Additional diagnostic work-up is
patient-dependent and only rarely applied and is therefore
not included in this model [18].
Analyses
The main outcome of both models was the incremental
cost-effectiveness ratio expressed as the extra costs that
need to be invested in order to get one more patient with
relief of abdominal pain. Two analyses were performed.
The first analysis focused on the incremental cost-effec-
tiveness of the new strategy in gallstone patients having a
cholecystectomy if one of two criteria would be fulfilled
compared with usual care. The second analysis focused on
the incremental cost-effectiveness of the new strategy in
gallstone patients having a cholecystectomy if two out of
two criteria would be fulfilled. Models were analyzed using
a probabilistic sensitivity analysis. With this analysis, the
model runs a 1000 times, each time picking another value
from the distribution underlying the input parameters. Beta
distributions for the probabilities of getting a cholecystec-
tomy and relief of abdominal pain were used. For the cost
parameters, however, no data were available to construct a
distribution. Results from the 1000 runs are graphically
presented as scatter plots on cost-effectiveness planes and
as means with 95 % percentiles.
Results
The results of the probabilistic sensitivity analysis of the
first decision model with the new strategy of gallstone
patients having a cholecystectomy if one of two criteria has
been satisfied are shown in Fig. 2. The new strategy was
more effective compared with the usual care strategy and
also less expensive. The mean percentage of patients with
absence of pain in the new strategy was 62 % (95 %
Surg Endosc (2017) 31:2534–2540 2535
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percentile 0.57–0.66), whereas with the usual care strategy
this was 57 % (95 % percentile 0.55–0.60). The costs of
the new strategy were €3610 (95 % percentile 3487–3722)
($4065; 95 % percentile 3927–4191), whereas the costs of
the usual care strategy was €3622 (95 % percentile
3536–3706) ($4078; 95 % percentile 3982–4173). The
mean cost difference was -€12 (95 % percentile
-134–105) (-$14; 95 % percentile -151–118) with a
mean effectiveness difference of 4.0 (95 % percentile
0.2–8.0) for the new strategy compared with the usual care
Fig. 1 Decision model
Table 1 Basic input variables and sources used in the decision model (shown in Fig. 1)
Input for the cost-effectiveness model Data source
Probability that a patient with abdominal symptoms and gallstones:
Satisfies one out of two criteria (thus receiving cholecystectomy) and
satisfies two out of two criteria (thus receiving cholecystectomy)
Prospective multicenter cohort study [14] (306/337 = 0.908) (138/
337 = 0.409)
Probability of receiving cholecystectomy in usual care strategy Prospective database of a multicenter cohort study [14] (0.911)
Probability of having a complication of the surgery Randomized controlled trial [17] (0.175)
Probability of having absence of pain after watchful waiting Prospective study [26](0.41)
Probability of having absence of pain after cholecystectomy in usual
care
Systematic review [13] (0.59)
Probability that a patient has absence of pain after cholecystectomy in
restrictive care: Satisfies one out of two criteria and satisfies two out
of two criteria
Prospective multicenter cohort study [14] (195/306 = 0.637) (100/
138 = 0.725)
Costs of watchful waiting (= 1 extra outpatient clinic visit) Cost-effectiveness guidelines [16] €314 ($354)
Costs Cholecystectomy including overnight stay, with or without
complications, outpatient clinic visit
Randomized controlled trial and cost-effectiveness guidelines [16, 17]
€4125 ($4645) with complications €3936 ($4432) without
complications
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strategy. Fifty-three percent of the simulations are located
in the dominant quadrant, meaning a higher percentage of
patients with relief of upper abdominal pain against lower
costs. The 95 % upper limit of the incremental cost-ef-
fectiveness ratio (ICER) is €4114 ($4633) per extra patient
with relief of upper abdominal pain. This implies that
€4114 ($4633) needs to be paid to relieve one extra patient
from his abdominal pain in this model.
The results of the probabilistic sensitivity analysis of the
second model with the new strategy of gallstone patients
having a cholecystectomy if both criteria have been satis-
fied are shown in Fig. 3. The mean percentage of patients
with absence of pain in the new strategy was 54 % (95 %
percentile 0.46–0.61), whereas with the usual care strategy
this was 57 % (95 % percentile 0.55–0.60) and therefore
more effective. The cost of the new strategy was €1675
(95 % percentile 1471–1886) ($1886; 95 % percentile
1656–2124), whereas the cost of the usual care strategy
was €3618 (95 % percentile 3527–3700) ($4074; 95 %
percentile 3972–4167). While in all simulations the new
strategy resulted in lower costs, only 16 % of the simula-
tions resulted in a higher percentage of patients with relief
of upper abdominal pain.
Discussion
This study showed that the strategy of using strict selection
criteria may be a cost-effective method to reduce the pro-
portion of patients with pain after cholecystectomy. The
strategy of applying one out of two criteria resulted in a
4 % higher mean proportion of patients with absence of
pain compared to current practice with similar costs. The
majority (54 %) of the simulations resulted in the restricted
care being dominant, meaning less expensive and more
effective. In those simulations, the restrictive care strategy
was more effective but also more expensive, and there was
a fair maximum to be paid per extra patient with relief of
abdominal pain. Application of the more stringent two out
of two criteria resulted in a 3 % lower mean proportion of
patients with absence of pain, but against lower costs.
In a previous study, we showed that duration of pain of
1 year or less has a slightly higher odds ratio for absence of
pain after cholecystectomy as compared to episodic
abdominal pain (2.22 vs. 2.13), although this difference is
not significant [14]. Altogether we would recommend to
implement the strategy of applying one out of two criteria.
Application of these criteria would offer surgeons less
room for personal preferences which patient to offer a
cholecystectomy and which patient to treat conservatively.
This strategy would therefore provide a tool for better
patient selection for each treatment arm. A recent cost-
effectiveness study reported in this journal comparing
cholecystectomy with observation for uncomplicated
symptomatic cholecystolithiasis or acute cholecystitis
reported that cholecystectomy is the preferred treatment for
symptomatic gallstones. On average, surgery costs £1236
(€1448; $1631) more per patient than conservative man-
agement, but was more effective. However, the study also
reported that 55 % of the patients randomized to the
Fig. 2 Probabilistic sensitivity
analysis of the model with the
new strategy of gallstone
patients having
cholecystectomy if one out of
two criteria have been satisfied
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observation group did not require surgery indicating that it
may be a valid alternative to surgery [19]. Application of
fixed criteria for cholecystectomy may increase the cost-
effectiveness of cholecystectomy and conservative treat-
ment as shown in this study.
Effectiveness of an intervention is often reported in cost-
effectiveness studies as quality-adjusted life years (QALY)
[19]. However, abdominal pain is the most characteristic
feature of uncomplicated symptomatic cholecystolithiasis
and therefore the main aim of cholecystectomy in this
patient group [3–6]. In addition, absence of pain after
cholecystectomy is the main predictor of a patient-reported
successful outcome of the operation [20]. The Gastroin-
testinal Quality of Life Index, a patient-reported outcome
measure computing quality of life, may not be sufficiently
disease-specific [21, 22]. Abdominal pain, for example, is
equally scored as flatulence in this questionnaire. Other
patient-reported outcome measures computing quality of
life are not different in weighing persistent abdominal pain
[23]. Furthermore, a quality of life score is less applicable
in surgical practice compared to presence or absence of
abdominal pain. We therefore selected absence of postop-
erative abdominal pain as effectiveness outcome.
This study must be considered within the context of
some limitations. First, the criteria for selection for
cholecystectomy remain non-specific, although they are
more specific than current practice entirely based on the
surgeons’ preference. Second, the criteria of the new
strategy were not externally validated, although this may
have been challenging to perform due to strong treatment
preferences of patients and surgeons [24–26]. Third, we
focused on uncomplicated symptomatic cholelithiasis
patients. Patients with complicated symptomatic
cholelithiasis were not considered. Exclusion of compli-
cated symptomatic cholelithiasis may not have had a large
impact as the patient group with uncomplicated symp-
tomatic cholelithiasis only have an annual 1–3 % risk on
complications because of the stones [27]. Furthermore, the
observation group of a randomized controlled trial of
patients with uncomplicated symptomatic cholecystolithi-
asis did not suffer complications during 14 years of follow-
up [28]. Fourth, we excluded patients having a bile duct
injury as this specific complication of cholecystectomy has
a low incidence of 0.04–1.5 % [29, 30]. Fifth, we did not
consider additional diagnostic work-up because of lack of
data, variability, and patient-dependency [18]. Finally, the
new strategy was evaluated from a healthcare perspective
for a time horizon of 1 year. If a societal perspective would
be taken into account, the restrictive care strategy of having
one out of two criteria satisfied would probably be even
more cost-effective, because this strategy was more
effective in terms of relief of abdominal pain and it pre-
vented cholecystectomies, probably preventing sick leave.
Especially, patients with ongoing abdominal pain after
cholecystectomy would continue to seek medical help with
additional diagnostic interventions.
This study should be considered a pilot study before
assessing the cost-effectiveness of the application of these
criteria in an actual trial. Apart from confirming these results
in a prospective randomized multicenter study, future
Fig. 3 Probabilistic sensitivity
analysis of the model with the
new strategy of gallstone
patients having
cholecystectomy if two out of
two criteria have been satisfied
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research should focus on further maximizing the cost-ef-
fectiveness of cholecystectomy. Determination of patients
with cholelithiasis at risk for complications due to the
gallstones may benefit from earlier cholecystectomy.
Selection for earlier surgery of those patients who are most
likely to benefit will further increase the cost-effectiveness
of this common surgical procedure. In addition, not only
should be assessed which patient will benefit from chole-
cystectomy, but also which patient will benefit most. Epi-
sodic abdominal pain due to gallstones may not significantly
affect the health status of all patients to that extent that a
cholecystectomy is required. The necessity may depend on
frequency, duration, and intensity of the abdominal pain
episodes [31]. Reliable prediction models combining clini-
cal parameters with patient-reported outcomemeasures may
facilitate efficient use of scarce healthcare resources [32].
In conclusion, the new strategywasmore effective, against
similar costs, than current practice if one out of two criteria
were applied.More stringent application of criteria resulted in
loss of effectiveness. The new strategy of using strict selection
criteriamaybea cost-effectivemethod to reduceproportion of
patients with pain after cholecystectomy.
Compliance with ethical standards
Disclosures Mark P. Lamberts, Cihan O¨zdemir, Joost P.H. Drenth,
Cornelis J.H.M. van Laarhoven, Gert P. Westert, Wietske Kievit have
no conflicts of interest or financial ties to disclose.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Festi D, Reggiani ML, Attili AF, Loria P, Pazzi P, Scaioli E,
Capodicasa S, Romano F, Roda E, Colecchia A (2010) Natural
history of gallstone disease: expectant management or active
treatment? results from a population-based cohort study. J Gas-
troenterol Hepatol 25:719–724
2. Shaffer EA (2006) Gallstone disease: epidemiology of gallblad-
der stone disease. Best Pract Res Clin Gastroenterol 20:981–996
3. The epidemiology of gallstone disease in Rome, Italy. Part II.
Factors associated with the disease. The Rome group for epi-
demiology and prevention of cholelithiasis (GREPCO). Hepa-
tology 8:907–913 (1988)
4. The epidemiology of gallstone disease in Rome, Italy. Part I. Preva-
lence data in men. The Rome group for epidemiology and prevention
of cholelithiasis (GREPCO). Hepatology 8:904–906 (1988)
5. Berger MY, Olde Hartman TC, van der Velden JJ, Bohnen AM
(2004) Is biliary pain exclusively related to gallbladder stones? A
controlled prospective study. Br J Gen Pract 54:574–579
6. Berger MY, van der Velden JJ, Lijmer JG, de Kort H, Prins A,
Bohnen AM (2000) Abdominal symptoms: do they predict gall-
stones? A systematic review. Scand J Gastroenterol 35:70–76
7. Gurusamy KS, Davidson BR (2014) Gallstones BMJ 348:g2669
8. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL,
Pinder EL (2003) The implications of regional variations in
Medicare spending. Part 2: health outcomes and satisfaction with
care. Ann Intern Med 138:288–298
9. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL,
Pinder EL (2003) The implications of regional variations in
Medicare spending. Part 1: the content, quality, and accessibility
of care. Ann Intern Med 138:273–287
10. Harrison EM, O’Neill S, Meurs TS, Wong PL, Duxbury M,
Paterson-Brown S, Wigmore SJ, Garden OJ (2012) Hospital
volume and patient outcomes after cholecystectomy in Scotland:
retrospective, national population based study. BMJ 344:e3330
11. Quintana JM, Cabriada J, Lopez de Tejada I, Perdigo L, Aros-
tegui I, Bilbao A, Garay I (2004) Appropriateness variation in
cholecystectomy. Eur J Public Health 14:252–257
12. Everhart JE, Ruhl CE (2009) Burden of digestive diseases in the
United States Part III: liver, biliary tract, and pancreas. Gas-
troenterology 136:1134–1144
13. Lamberts MP, Lugtenberg M, Rovers MM, Roukema AJ, Drenth
JP, Westert GP, van Laarhoven CJ (2013) Persistent and de novo
symptoms after cholecystectomy: a systematic review of chole-
cystectomy effectiveness. Surg Endosc 27:709–718
14. Lamberts MP, Den Oudsten BL, Gerritsen JJ, Roukema JA,
Westert GP, Drenth JP, van Laarhoven CJ (2015) Prospective
multicentre cohort study of patient-reported outcomes after
cholecystectomy for uncomplicated symptomatic cholecys-
tolithiasis. Br J Surg 102:1402–1409
15. Thistle JL, Longstreth GF, Romero Y, Arora AS, Simonson JA,
Diehl NN, Harmsen WS, Zinsmeister AR (2011) Factors that
predict relief from upper abdominal pain after cholecystectomy.
Clin Gastroenterol Hepatol 9:891–896
16. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM (2010) Han-
dleiding voor kostenonderzoek, methoden en standaard kostpri-
jzen voor economische evaluaties in de gezondheidszorg. College
voor zorgverzekeringen. Geactualiseerde versie 2010
17. Keus F, de Jonge T, Gooszen HG, Buskens E, van Laarhoven CJ
(2009) Cost-minimization analysis in a blind randomized trial on
small-incision versus laparoscopic cholecystectomy from a
societal perspective: sick leave outweighs efforts in hospital
savings. Trials 10:80
18. Lamberts MP, Kievit W, Ozdemir C, Westert GP, van Laarhoven
CJ, Drenth JP (2015) Value of EGD in patients referred for
cholecystectomy: a systematic review and meta-analysis. Gas-
trointest Endosc 82:24–31
19. Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F,
McNamee P, Elders A, Fraser C, Avenell A, Ramsay C (2015)
Systematic review of the clinical and cost effectiveness of
cholecystectomy versus observation/conservative management
for uncomplicated symptomatic gallstones or cholecystitis. Surg
Endosc 29:637–647
20. Weinert CR, Arnett D, Jacobs D Jr, Kane RL (2000) Relationship
between persistence of abdominal symptoms and successful
outcome after cholecystectomy. Arch Intern Med 160:989–995
21. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Sch-
mulling C, Neugebauer E, Troidl H (1995) Gastrointestinal
quality of life index: development, validation and application of a
new instrument. Br J Surg 82:216–222
22. Nieveen Van Dijkum EJ, Terwee CB, Oosterveld P, Van Der
Meulen JH, Gouma DJ, De Haes JC (2000) Validation of the
gastrointestinal quality of life index for patients with potentially
operable periampullary carcinoma. Br J Surg 87:110–115
Surg Endosc (2017) 31:2534–2540 2539
123
23. Vetrhus M, Soreide O, Eide GE, Solhaug JH, Nesvik I, Sondenaa
K (2004) Pain and quality of life in patients with symptomatic,
non-complicated gallbladder stones: results of a randomized
controlled trial. Scand J Gastroenterol 39:270–276
24. Bowling A, Rowe G, Lambert N, Waddington M, Mahtani KR,
Kenten C, Howe A, Francis SA (2012) The measurement of
patients’ expectations for health care: a review and psychometric
testing of a measure of patients’ expectations. Health Technol
Assess 16:i-xii, 1-509
25. Jones KR, Burney RE, Christy B (2000) Patient expectations for
surgery: are they being met? Jt Comm J Qual Improv 26:349–360
26. Vetrhus M, Soreide O, Solhaug JH, Nesvik I, Sondenaa K (2002)
Symptomatic, non-complicated gallbladder stone disease. Oper-
ation or observation? A randomized clinical study. Scand J
Gastroenterol 37:834–839
27. Friedman GD (1993) Natural history of asymptomatic and
symptomatic gallstones. Am J Surg 165:399–404
28. Schmidt M, Sondenaa K, Vetrhus M, Berhane T, Eide GE (2011)
A randomized controlled study of uncomplicated gallstone dis-
ease with a 14-year follow-up showed that operation was the
preferred treatment. Dig Surg 28:270–276
29. Eikermann M, Siegel R, Broeders I, Dziri C, Fingerhut A, Gutt C,
Jaschinski T, Nassar A, Paganini AM, Pieper D, Targarona E,
Schrewe M, Shamiyeh A, Strik M, Neugebauer EA, Euro-
peanAssociation for Endoscopic S (2012) Prevention and treat-
ment of bile duct injuries during laparoscopic cholecystectomy:
the clinical practice guidelines of the European Association for
Endoscopic Surgery (EAES). Surg Endosc 26:3003–3039
30. Tornqvist B, Stromberg C, Persson G, Nilsson M (2012) Effect of
intended intraoperative cholangiography and early detection of
bile duct injury on survival after cholecystectomy: population
based cohort study. BMJ 345:e6457
31. Berhane T, Vetrhus M, Hausken T, Olafsson S, Sondenaa K
(2006) Pain attacks in non-complicated and complicated gall-
stone disease have a characteristic pattern and are accompanied
by dyspepsia in most patients: the results of a prospective study.
Scand J Gastroenterol 41:93–101
32. American College of P (2008) Information on cost-effectiveness:
an essential product of a national comparative effectiveness
program. Ann Intern Med 148:956–961
2540 Surg Endosc (2017) 31:2534–2540
123
